Autopsy report · NCT02584829
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Cause of deathFunding or business
“Terminated due to loss in funding”
Life of this trial
- Ran for about 3 years 1 month before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 3 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Fred Hutchinson Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Merkel Cell Polyomavirus Infection; Stage IV Merkel Cell Carcinoma AJCC v7
- Interventions
- Avelumab; Laboratory Biomarker Analysis; MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells; Radiation Therapy; Recombinant Interferon Beta
- Participants
- 8
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
“Terminated due to loss of funding” - IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
“Terminated due to lack of funding” - Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
“Terminated due to insufficient funding” - The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
“Funding was terminated” - Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
“Funding terminated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.